2.4. Analysis.
Comparison 2 High‐dose compared to low‐dose recombinant factor VIIIa (rFVIIIa), Outcome 4 Number of serious adverse events.
Comparison 2 High‐dose compared to low‐dose recombinant factor VIIIa (rFVIIIa), Outcome 4 Number of serious adverse events.